Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
Аll
2024
2023
2022
2021
2020
2019
2018
2017
01.08.2023
The Pharmasyntez Group of Companies at the second Russia-Africa Summit
Read more
25.07.2023
The Pharmasyntez Group of Companies enters the Ecuador Market
Read more
24.07.2023
The Pharmasyntez Group of Companies is in the TOP 3 pharmaceutical companies in terms of supplies in the 1st quarter of 2023
Read more
14.07.2023
Increase in cancer incidence: challenges and statistics
Read more
13.07.2023
The Pharmasyntez Group of Companies enters the Syrian Market
Read more
05.07.2023
Summer internship at the Pharmasyntez-Tyumen plant
Read more
03.07.2023
The Pharmasyntez Group of Companies starts production of gensulins in Russia
Read more
27.06.2023
"A powerful energy boost and a sense of unity"
Read more
18.06.2023
It was hot!
Read more
15.06.2023
The Pharmasyntez Group is investing 5 billion rubles in the construction of the fourth stage of the Pharmasyntez-Nord pharmaceutical complex
Read more
15.06.2023
Pharmasyntez and Irkutsk Region defined social activities for 2023
Read more
14.06.2023
The Kaluga Region and the Pharmasyntez Group of Companies signed 3 investment agreements worth more than 20 billion rubles
Read more
04.06.2023
A scholarship holder from the Pharmasyntez Group of Companies won the Grand Prix gold in Dushanbe
Read more
30.05.2023
Pharmasyntez is general sponsor of the Congress of Endocrinologists: Personalized Medicine and Practical Healthcare.
Read more
25.05.2023
Pharmasyntez at the III Young Scientists School of the Mendeleev University of Chemical Technology of Russia
Read more
24.05.2023
The Pharmasyntez Group of Companies is a participant of the XIX Republican Scientific and Practical Conference: Modern Technologies in Diagnosis and Treatment of Tumors.
Read more
News:
← предыдущая
2
3
4
5
6
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez